314 related articles for article (PubMed ID: 10703934)
1. Early postmenopausal bone loss is associated with PvuII estrogen receptor gene polymorphism in Finnish women: effect of hormone replacement therapy.
Salmén T; Heikkinen AM; Mahonen A; Kröger H; Komulainen M; Saarikoski S; Honkanen R; Mäenpää PH
J Bone Miner Res; 2000 Feb; 15(2):315-21. PubMed ID: 10703934
[TBL] [Abstract][Full Text] [Related]
2. The protective effect of hormone-replacement therapy on fracture risk is modulated by estrogen receptor alpha genotype in early postmenopausal women.
Salmén T; Heikkinen AM; Mahonen A; Kröger H; Komulainen M; Saarikoski S; Honkanen R; Mäenpää PH
J Bone Miner Res; 2000 Dec; 15(12):2479-86. PubMed ID: 11127213
[TBL] [Abstract][Full Text] [Related]
3. Leucine7 to proline7 polymorphism in prepro-NPY gene and femoral neck bone mineral density in postmenopausal women.
Heikkinen AM; Niskanen LK; Salmi JA; Koulu M; Pesonen U; Uusitupa MI; Komulainen MH; Tuppurainen MT; Kröger H; Jurvelin J; Saarikoski S
Bone; 2004 Sep; 35(3):589-94. PubMed ID: 15336593
[TBL] [Abstract][Full Text] [Related]
4. Relation of androgen receptor gene polymorphism to bone mineral density and fracture risk in early postmenopausal women during a 5-year randomized hormone replacement therapy trial.
Salmén T; Heikkinen AM; Mahonen A; Kröger H; Komulainen M; Pallonen H; Saarikoski S; Honkanen R; Mäenpää PH
J Bone Miner Res; 2003 Feb; 18(2):319-24. PubMed ID: 12568409
[TBL] [Abstract][Full Text] [Related]
5. [The influence of hormonal replacement therapy on bone density in postmenopausal women depending on polymorphism of vitamin D receptor (VDR) and estrogen receptor (ER) genes].
Brodowska A
Ann Acad Med Stetin; 2003; 49():111-30. PubMed ID: 15552843
[TBL] [Abstract][Full Text] [Related]
6. COL1A1 Sp1 polymorphism predicts perimenopausal and early postmenopausal spinal bone loss.
MacDonald HM; McGuigan FA; New SA; Campbell MK; Golden MH; Ralston SH; Reid DM
J Bone Miner Res; 2001 Sep; 16(9):1634-41. PubMed ID: 11547832
[TBL] [Abstract][Full Text] [Related]
7. Estrogen receptor (ER) gene polymorphism may predict the bone mineral density response to raloxifene in postmenopausal women on chronic hemodialysis.
Heilberg IP; Hernandez E; Alonzo E; Valera R; Ferreira LG; Gomes SA; Bellorin-Font E; Weisinger JR
Ren Fail; 2005; 27(2):155-61. PubMed ID: 15807179
[TBL] [Abstract][Full Text] [Related]
8. [Study on the relationship between some genetic factors and peak bone mineral density in Beijing young women].
Yang X; Zheng SR; Chen RJ; Chen SL; Fan ZH; Li H; Lu YH
Zhonghua Fu Chan Ke Za Zhi; 2003 May; 38(5):273-6. PubMed ID: 12895309
[TBL] [Abstract][Full Text] [Related]
9. Estrogen receptor alpha gene polymorphisms are associated with changes in bone remodeling markers and treatment response to estrogen.
Rapuri PB; Gallagher JC; Knezetic JA; Haynatzka V
Maturitas; 2006 Mar; 53(4):371-9. PubMed ID: 16139450
[TBL] [Abstract][Full Text] [Related]
10. Estrogen receptor alpha gene polymorphisms and bone mineral density: haplotype analysis in women from the United Kingdom.
Albagha OM; McGuigan FE; Reid DM; Ralston SH
J Bone Miner Res; 2001 Jan; 16(1):128-34. PubMed ID: 11149476
[TBL] [Abstract][Full Text] [Related]
11. [Relationship between estrogen receptor genotypes and female bone mineral density].
Zhang Q; Yang D; Kuang J
Zhonghua Fu Chan Ke Za Zhi; 2001 Jun; 36(6):344-7. PubMed ID: 11783132
[TBL] [Abstract][Full Text] [Related]
12. [Association of bone mineral density with gene polymorphisms and environmental factors in Chinese postmenopausal women].
Dong J; Huang ZW; Piao JH; Gong J
Wei Sheng Yan Jiu; 2006 Mar; 35(2):196-200. PubMed ID: 16758971
[TBL] [Abstract][Full Text] [Related]
13. Relation of estrogen receptor-alpha gene polymorphism and hormone replacement therapy to fall risk and muscle strength in early postmenopausal women.
Salmén T; Heikkinen AM; Mahonen A; Kröger H; Komulainen M; Saarikoski S; Honkanen R; Partanen J; Mäenpää PH
Ann Med; 2002; 34(1):64-72. PubMed ID: 12014437
[TBL] [Abstract][Full Text] [Related]
14. Estrogen receptor gene polymorphisms and bone mineral density in Chinese postmenopausal women.
Liu J; Zhu H; Zhu X; Dai M; Jiang L; Xu M; Chen J
Chin Med J (Engl); 2003 Mar; 116(3):364-7. PubMed ID: 12781038
[TBL] [Abstract][Full Text] [Related]
15. Prediction of bone mineral density from vitamin D receptor polymorphisms is uncertain in representative samples of Japanese Women. The Japanese Population-based Osteoporosis (JPOS) Study.
Morita A; Iki M; Dohi Y; Ikeda Y; Kagamimori S; Kagawa Y; Matsuzaki T; Yoneshima H; Marumo F;
Int J Epidemiol; 2004 Oct; 33(5):979-88. PubMed ID: 15358739
[TBL] [Abstract][Full Text] [Related]
16. Lack of association between estrogen receptor genotypes and bone mineral density, fracture history, or muscle strength in elderly women.
Vandevyver C; Vanhoof J; Declerck K; Stinissen P; Vandervorst C; Michiels L; Cassiman JJ; Boonen S; Raus J; Geusens P
J Bone Miner Res; 1999 Sep; 14(9):1576-82. PubMed ID: 10469287
[TBL] [Abstract][Full Text] [Related]
17. Risk factors associated with peri- and postmenopausal bone loss: does HRT prevent weight loss-related bone loss?
Sirola J; Kröger H; Honkanen R; Sandini L; Tuppurainen M; Jurvelin JS; Saarikoski S
Osteoporos Int; 2003 Jan; 14(1):27-33. PubMed ID: 12577182
[TBL] [Abstract][Full Text] [Related]
18. Prevention of femoral and lumbar bone loss with hormone replacement therapy and vitamin D3 in early postmenopausal women: a population-based 5-year randomized trial.
Komulainen M; Kröger H; Tuppurainen MT; Heikkinen AM; Alhava E; Honkanen R; Jurvelin J; Saarikoski S
J Clin Endocrinol Metab; 1999 Feb; 84(2):546-52. PubMed ID: 10022414
[TBL] [Abstract][Full Text] [Related]
19. Association of vitamin D and estrogen receptor gene polymorphism with the effects of longterm hormone replacement therapy on bone mineral density.
Kurabayashi T; Matsushita H; Tomita M; Kato N; Kikuchi M; Nagata H; Honda A; Yahata T; Tanaka K
J Bone Miner Metab; 2004; 22(3):241-7. PubMed ID: 15108066
[TBL] [Abstract][Full Text] [Related]
20. Does vitamin D strengthen the increase in femoral neck BMD in osteoporotic women treated with estrogen?
Tuppurainen MT; Komulainen M; Kröger H; Honkanen R; Jurvelin J; Puntila E; Heikkinen AM; Alhava E; Saarikoski S
Osteoporos Int; 1998; 8(1):32-8. PubMed ID: 9692075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
